Answers are grounded in this paper and cite their sources.
Novel tumor‐targeting titanium dioxide (TiO 2 ) nanoparticles modified with hyaluronic acid (HA) were developed to explore the feasibility of exploiting the pH‐responsive drug release property of TiO 2 and the tumor‐targeting ability of HA to construct a tumor‐targeting cisplatin (CDDP) delivery system (HA‐TiO 2 ) for potential neoadjuvant chemotherapy of ovarian cancer. The experimental results indicated that CDDP release from the HA‐TiO 2 nanoparticles was significantly accelerated by decreasing pH from 7.4 to 5.0, which is of particular benefit to cancer therapy. CDDP‐loaded HA‐TiO 2 nanoparticles increased the accumulation of CDDP in A2780 ovarian cancer cells via HA‐mediated endocytosis and exhibited superior anticancer activity in vitro . In vivo real‐time imaging assay revealed that HA‐TiO 2 nanoparticles possessed preferable tumor‐targeting ability which might potentially minimize the toxic side effects of CDDP in clinical application.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: